Skip to main content
PreveCeutical Medical logo

PreveCeutical Medical — Investor Relations & Filings

Ticker · PREV ISIN · CA74143C1068 LEI · 96760001OJCSH5MXZ450 CSE Professional, scientific and technical activities
Open in API
Filings indexed 438 across all filing types
Latest filing 2026-05-21 Regulatory Filings
Country CA Canada
Listing CSE PREV

About PreveCeutical Medical

https://www.preveceutical.com/

PreveCeutical Medical Inc. is a health sciences company dedicated to the research and development of innovative options for preventive and curative therapies. The company specializes in utilizing organic and nature identical products, combining scientific rigor with natural sources to benefit health-conscious consumers. Its primary focus is on the preventive health sector, collaborating with partners to bring novel solutions to market.

Recent filings

Filing Released Lang Actions
Report of exempt distribution (45-106F1) (amended).pdf
Regulatory Filings Classification · 85% confidence The document is a detailed Canadian securities regulatory filing (Form 45-106F1 Report of Exempt Distribution) providing compliance information about an exempt distribution of securities. It is not a general market announcement like an earnings release or investor presentation, nor is it a financial report (10-K, IR) or management discussion. It is a specialized compliance report and thus falls under the fallback category for miscellaneous regulatory filings. Therefore, it should be classified as Regulatory Filings (RNS).
2026-05-21 English
News release - English.pdf
Capital/Financing Update Classification · 94% confidence The document is a news release announcing an extension of a non-brokered private placement, detailing the offering of units, warrants, use of proceeds, closing dates, and related financing terms. This is an update on company fundraising activities, which falls squarely under Capital/Financing Update (CAP).
2026-05-20 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings Classification · 85% confidence The document is a standardized Canadian securities regulatory form – Form 45-106F1 – used to report an exempt distribution to securities authorities (SEDAR+). It contains detailed compliance disclosures (issuer details, distribution schedule, purchaser information, compensation) rather than financial statements or management commentary. This is a general regulatory filing, not an annual or interim financial report, call transcript, or other specific category. Therefore it falls under the Regulatory Filings (RNS) category.
2026-05-20 English
Material change report - English.pdf
Regulatory Filings
2026-05-13 English
News release - English.pdf
Regulatory Filings
2026-05-12 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings
2026-05-01 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.